24. Infectious Diseases III: Antifungals + Antivirals Flashcards
Zygomycetes refers to a class of fungi which includes ___ and __ species; invasive disease caused by these species is commonly referred to as “____”
Mucor
Rhizopus
Mucormycosis
Aphotericin B coverage
Broad-spectrum
Active against:
Yeasts - most Candida species and Cryptococcus neoformans
Molds - Aspergillus species and Zygomycetes
Dimorphic fungi - Histoplasma capsulatum, Blastomyces dermatitidis, and Coccidioides immitis
There are two types of Amphotericin B formulations: conventional and lipid. Which one is a/w fewer toxicities?
Lipid formulations are a/w fewer toxicities (e.g. decreased infusion reactions, decreased nephrotoxicity) compared to conventional (deoxycholate) formulations
Boxed warning for Amphotericin B
Medication errors confusing lipid (AmBisome and Abelcet) vs conventional formulation (dexoxycholate)
Conventional dose should not exceed 1.5mg/kg/day (verify product name and dose if it exceeds 1.5 mg/kg/day)
Conventional amphotericin B should NOT exceed _____mg/kg/day
1.5mg/kg/day
Side effects for amphotericin B
Infusion-related: fever chills, HA, malaise, rigors, decreased or increased bP, thrombophlebitis, N/V
Decreased K, Mg, nephrotoxicity, enamia
Ambisome: severe back/chest pain with first dose
Preparation notes for amphotericin B
Compatible with D5W ONLY
Lipid formulations must be filtered during preparation
Which amphotericin B formulation must be filtered during preparation
Lipid formulations
Which amphotericin B formulation requires premedication to reduce infusion related reactions?
Conventional (deoxycholate) formulation
What should you give as premedication before amphotericin B deoxycholate administration (30-60min before)?
APAP or NSAID
Diphenhydramine and/or hydrocortisone
NS bolus to decrease risk of nephrotoxicity
± meperidine to decrease duration of severe rigors
What color is amphotericin B (both lipid and conventional formulations)?
Yellow-orange
Amphotericin B was ordered for one of your transplant patients for fungal infection. Current med list includes tacrolimus. What is your concern with the new medication?
Additive risk of nephrotoxicity with other nephrotoxic agents like aminoglycosides, cisplatin, polymixins, cyclosporine, loop diuretics, NSAIDs, radiocontrast dye, tacrolimus, and vancomycin
Amphotericin B can increase risk of digoxin toxicity d/t ____
hypokalemia
Use caution with any agent that decreases K or Mg
MOA Flucytosine
Penetrates fungal cells and is converted to fluorouracil, which competes with uracil and interferes with fungal RNA and protein synthesis
Patient cultures were positive for Candida infection. Doctor prescribed flucytosine monotherapy regimen. What is your concern
D/t resistance, flucytosine should NOT be used alone. Recommended in combination with amphotericin B for treatment of invasive cryptococcal (e.g. meningitis) or Candida infections.
Boxed warning for flucytosine (5-FC) (Ancobon)
Use with extreme caution in pts with renal dysfunction; monitor hematologic, renal and hepatic status
Side effects for flucytosine (5-FC) (Ancobon)
Myelosuppression (anemia, neutropenia, thrombocytopenia)
Others: increased SCr, BUN, liver injury, increased bilirubin, many CNS effects, hypoglycemia, decreased K, and aplastic anemia
MOA of azole antifungals
Decrease ergosterol synthesis and cell membrane formation
Azole antifungal use is sometimes limited d/t drug interactions caused by _____
CYP450 (mainly 3A4) inhibition
Fluconazole has coverage against C. albicans, C. parapsilosis, and C. tropicalis but limited efficacy against ___ and ___ d/t resistance
C. qlabrata
C. krusei
Common uses for Fluconazole
Many infections, including yeast infections (e.g oral, esophageal, vaginal) and nail bed infections (onychomycosis)
Common uses for itraconazole
Dimorphic fungi (Blastomycoes and Histoplasma) and nail bed infections
____ is the treatment of choice for Aspergillus
Voriconazole
Fluconazole (Diflucan) dosing
50-800mg PO/IV daily
Vaginal candidiasis: 150mg PO x1
CrCl ≤50: decrease dose by 50%